Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):96–8.
Krotulski AJ, Mohr ALA, Kacinko SL, et al. 4F-MDMB-BINACA: A new synthetic cannabinoid widely implicated in forensic casework. J Forensic Sci. 2019;64:1451–61.
Banister SD, Stuart J, Kevin RC, et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 2015;6:1445–58.
World Health Organization. Critical Review Report: 4F-MDMB-BINACA. WHO expert committe drug depend. 2019.
Haschimi B, Mogler L, Halter S, et al. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in “legal high” products and human urine specimens. Drug Test Anal. 2019;11:1377–86.
Belze O, Legras A, Ehrmann S, et al. Cannabis-induced acute pancreatitis. Am J Emerg Med. 2011;29(131):e3-4.
Juan-Picó P, Fuentes E, Javier Bermúdez-Silva F, et al. Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell. Cell Calcium. 2006;39:155–62.
Linari G, Agostini S, Amadoro G, et al. Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacol Res. 2009;59:207–14.
Wargo KA, Geveden BN, McConnell VJ. Cannabinoid-induced pancreatitis: A case series. J Pancreas. 2007;8:579–83.
Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: Clinical and laboratory findings. Addiction. 2013;108:534–44.
Centers for Disease Control and Prevention. Notes from the field: Hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase—Denver, Colorado, 2012. JAMA. 2013;6:108.
Silva JP, Carmo H, Carvalho F. The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis. Toxicol Lett. 2018;287:59–69.
Buser GL, Gerona RR, Horowitz BZ, et al. Acute kidney injury associated with smoking synthetic cannabinoid. Clin Toxicol. 2014;52:664–73.
Araujo TT, Barbosa Silva Pereira HA, Dionizio A, et al. Changes in energy metabolism induced by fluoride: Insights from inside the mitochondria. Chemosphere. 2019;236:124357.
Usuda K, Kono K, Dote T, et al. Usefulness of the assessment of urinary enzyme leakage in monitoring acute fluoride nephrotoxicity. Arch Toxicol. 1999;73:346–51.
Barbier O, Arreola-Mendoza L, Del Razo LM. Molecular mechanisms of fluoride toxicity. Chem Biol Interact. 2010;188:319–33.
Song C, Fu B, Zhang J, et al. Sodium fluoride induces nephrotoxicity via oxidative stress-regulated mitochondrial SIRT3 signaling pathway. Sci Rep. 2017;7:672.
Larsson A, Ristoff E, Anderson ME. Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. Metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995.